FIA
RVMD icon

FNY Investment Advisers’s Revolution Medicines RVMD Stock Holding History

FNY Investment Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-105
Closed -$4K – 949
2024
Q4 		$4K Buy
+105
New +$5.3K ﹤0.01% 554

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return

FNY Investment Advisers's RVMD Position: Q2 2026 in Review

FNY Investment Advisers sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 1,310 shares — an estimated $191K sold.

FNY Investment Advisers first reported a position in RVMD in Q3 2025 and held it in 2 quarters. The position peaked at $127K in Q1 2026. 317 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • FNY Investment Advisers reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 1,310 Revolution Medicines shares in Q2 2026, an estimated $191K.
  • FNY Investment Advisers first reported a position in Revolution Medicines in Q3 2025 and held it in 2 quarters.
  • FNY Investment Advisers's Revolution Medicines position peaked at $127K in Q1 2026.
  • 317 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.